The two companies have plans to create a joint venture under the name Pharma & Beauty International (PBI), with Cetes Cosmetics as a minor shareholder

Thanks to the complementarity of their two production networks and of their customer portfolios, the two companies intend to position PBI as a new global cosmetic subcontractor in order to meet the increasingly diverse needs of beauty brands around the world.

Cetes Cosmetics is the manufacturing arm of Swedish cosmetics group Oriflamme, but also produces cosmetics for external third-party customers.

Created in 2012 by Laurent Dodet and Jean-Marie Total, France’s Pharma & Beauty Group operates four factories in France and specializes in the manufacture and filling of cosmetic (skincare, make-up, perfume, hygiene) and pharmaceutical products (medical devices, pharmaceuticals) and dietary supplements. Pharma & Beauty Group has a strong position as a contract manufacturer in France. For its part, Cetes Cosmetics is the manufacturing arm of Swedish cosmetics group Oriflame. Established in 2017 with headquarters in Schaffhausen, Switzerland, Cetes Cosmetics has six plants in four countries (Poland, Russia, India and China). The company manufactures cosmetic products for both Oriflame and for external third-party customers.

PBI will be incorporated in France with headquarters in Paris and will be headed by Laurent Dodet as CEO.

The new entity will have 10 industrial sites in France, Poland, Russia, India and China, to meet the diverse needs of beauty brands around the world.

“With PBI we will bring together the best from both partners; global footprint, wide range of technologies, breakthrough innovations, high-quality factories and a dynamic experienced management. PBI will be able to offer clients flexible production solutions in the combined 10 factories of both joint venture partners,” said Laurent Dodet in a release.